BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 27582542)

  • 21. Benzyl isothiocyanate (BITC) induces G2/M phase arrest and apoptosis in human melanoma A375.S2 cells through reactive oxygen species (ROS) and both mitochondria-dependent and death receptor-mediated multiple signaling pathways.
    Huang SH; Wu LW; Huang AC; Yu CC; Lien JC; Huang YP; Yang JS; Yang JH; Hsiao YP; Wood WG; Yu CS; Chung JG
    J Agric Food Chem; 2012 Jan; 60(2):665-75. PubMed ID: 22148415
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Inhibition of human melanoma growth by a non-cardioselective β-blocker.
    Wrobel LJ; Le Gal FA
    J Invest Dermatol; 2015 Feb; 135(2):525-531. PubMed ID: 25178102
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Moxidectin inhibits glioma cell viability by inducing G0/G1 cell cycle arrest and apoptosis.
    Song D; Liang H; Qu B; Li Y; Liu J; Chen C; Zhang D; Zhang X; Gao A
    Oncol Rep; 2018 Sep; 40(3):1348-1358. PubMed ID: 30015956
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of SOCS1 silencing on proliferation and apoptosis of melanoma cells: An in vivo and in vitro study.
    Yu SJ; Long ZW
    Tumour Biol; 2017 May; 39(5):1010428317694315. PubMed ID: 28466787
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A novel arylbenzofuran induces cervical cancer cell apoptosis and G1/S arrest through ERK-mediated Cdk2/cyclin-A signaling pathway.
    Ming P; Cai T; Li J; Ning Y; Xie S; Tao T; Tang F
    Oncotarget; 2016 Jul; 7(27):41843-41856. PubMed ID: 27259234
    [TBL] [Abstract][Full Text] [Related]  

  • 26. In vitro and in vivo anti-tumor activity of CoQ0 against melanoma cells: inhibition of metastasis and induction of cell-cycle arrest and apoptosis through modulation of Wnt/β-catenin signaling pathways.
    Hseu YC; Thiyagarajan V; Tsou HT; Lin KY; Chen HJ; Lin CM; Liao JW; Yang HL
    Oncotarget; 2016 Apr; 7(16):22409-26. PubMed ID: 26968952
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A DC-81-indole conjugate agent suppresses melanoma A375 cell migration partially via interrupting VEGF production and stromal cell-derived factor-1α-mediated signaling.
    Hsieh MC; Hu WP; Yu HS; Wu WC; Chang LS; Kao YH; Wang JJ
    Toxicol Appl Pharmacol; 2011 Sep; 255(2):150-9. PubMed ID: 21708181
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Bufalin induces G0/G1 phase arrest through inhibiting the levels of cyclin D, cyclin E, CDK2 and CDK4, and triggers apoptosis via mitochondrial signaling pathway in T24 human bladder cancer cells.
    Huang WW; Yang JS; Pai SJ; Wu PP; Chang SJ; Chueh FS; Fan MJ; Chiou SM; Kuo HM; Yeh CC; Chen PY; Tsuzuki M; Chung JG
    Mutat Res; 2012 Apr; 732(1-2):26-33. PubMed ID: 22285700
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The β-adrenoceptor antagonist, propranolol, induces human gastric cancer cell apoptosis and cell cycle arrest via inhibiting nuclear factor κB signaling.
    Liao X; Che X; Zhao W; Zhang D; Bi T; Wang G
    Oncol Rep; 2010 Dec; 24(6):1669-76. PubMed ID: 21042766
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Antibiotic drug tigecycline reduces neuroblastoma cells proliferation by inhibiting Akt activation in vitro and in vivo.
    Zhong X; Zhao E; Tang C; Zhang W; Tan J; Dong Z; Ding HF; Cui H
    Tumour Biol; 2016 Jun; 37(6):7615-23. PubMed ID: 26687647
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Juniperus indica Bertol. extract synergized with cisplatin against melanoma cells via the suppression of AKT/mTOR and MAPK signaling and induction of cell apoptosis.
    Huang XF; Gao HW; Lee SC; Chang KF; Tang LT; Tsai NM
    Int J Med Sci; 2021; 18(1):157-168. PubMed ID: 33390784
    [No Abstract]   [Full Text] [Related]  

  • 32. Use of non-selective β-blockers is associated with decreased tumor proliferative indices in early stage breast cancer.
    Montoya A; Amaya CN; Belmont A; Diab N; Trevino R; Villanueva G; Rains S; Sanchez LA; Badri N; Otoukesh S; Khammanivong A; Liss D; Baca ST; Aguilera RJ; Dickerson EB; Torabi A; Dwivedi AK; Abbas A; Chambers K; Bryan BA; Nahleh Z
    Oncotarget; 2017 Jan; 8(4):6446-6460. PubMed ID: 28031536
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Synergistic cooperation between ABT-263 and MEK1/2 inhibitor: effect on apoptosis and proliferation of acute myeloid leukemia cells.
    Airiau K; Prouzet-Mauléon V; Rousseau B; Pigneux A; Jeanneteau M; Giraudon M; Allou K; Dubus P; Belloc F; Mahon FX
    Oncotarget; 2016 Jan; 7(1):845-59. PubMed ID: 26625317
    [TBL] [Abstract][Full Text] [Related]  

  • 34. LYG-202 exerts antitumor effect on PI3K/Akt signaling pathway in human breast cancer cells.
    Zhao Y; Wang X; Sun Y; Zhou Y; Yin Y; Ding Y; Li Z; Guo Q; Lu N
    Apoptosis; 2015 Sep; 20(9):1253-69. PubMed ID: 26153346
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Overexpression of Mcl-1 confers resistance to BRAFV600E inhibitors alone and in combination with MEK1/2 inhibitors in melanoma.
    Fofaria NM; Frederick DT; Sullivan RJ; Flaherty KT; Srivastava SK
    Oncotarget; 2015 Dec; 6(38):40535-56. PubMed ID: 26497853
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Trifluoperazine Inhibits Mesangial Cell Proliferation by Arresting Cell Cycle-Dependent Mechanisms.
    Wang B; Zhou X; Wang Y; Li R
    Med Sci Monit; 2017 Jul; 23():3461-3469. PubMed ID: 28713151
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Dual PI3K/mTOR inhibitor BEZ235 exerts extensive antitumor activity in HER2-positive gastric cancer.
    Zhu Y; Tian T; Zou J; Wang Q; Li Z; Li Y; Liu X; Dong B; Li N; Gao J; Shen L
    BMC Cancer; 2015 Nov; 15():894. PubMed ID: 26560145
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The herbal medicine Cyperus amuricus inhibits proliferation of human hepatocellular carcinoma Hep3B cells by inducing apoptosis and arrest at the G0/G1 cell cycle phase.
    Pham HH; Seong YA; Oh CW; Kim GD
    Int J Oncol; 2016 Nov; 49(5):2046-2054. PubMed ID: 27667556
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Small molecule inhibition of polo-like kinase 1 by volasertib (BI 6727) causes significant melanoma growth delay and regression in vivo.
    Cholewa BD; Ndiaye MA; Huang W; Liu X; Ahmad N
    Cancer Lett; 2017 Jan; 385():179-187. PubMed ID: 27793694
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pre-clinical assessment of A-674563 as an anti-melanoma agent.
    Zou Y; Fan G; Wang X
    Biochem Biophys Res Commun; 2016 Aug; 477(1):1-8. PubMed ID: 26970307
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.